What makes us different?
The government’s ever-increasing role as both regulator and payer is increasingly opaque, with massive implications for companies and investors alike. Legislators and regulators make critical decisions every day on healthcare issues that affect communities, and Capstone’s access to the policy world allows us to provide an array of insights. From micro studies of medical facilities to macro views of healthcare technology policy trends on the horizon, we provide clients differentiated investment ideas as well as deep-dive regulatory due diligence.
We live in the weeds.
Corporations and investors lean on Capstone’s expertise in healthcare policy to gain valuable insights on regulatory risks and global opportunities. Our process is designed to uncover innovative policy-driven ideas, advising private equity firms, corporations, and investors on the impact of regulation on potential and existing investments. We leverage our ability to wade through public records of existing and proposed regulation, legislation, and other policy efforts. We combine that with our relationships with major industry associations, as well as senior policymakers and influential experts, to add value and identify opportunities for investment growth.
Employee Retirement Income Security Act (ERISA)
Affordable Care Act
Pharmaceutical supply chain
Healthcare financial services
Our Latest Insights
Bigger, Badder, and More Coordinated Tech Regulation Download January 24, 2022 Federal agencies—better aligned and staffed up than last year—will be the primary driver of a stricter and more onerous technology regulatory push in 2022, with advancement on antitrust,...
Crypto Clarity and Forced Hands Download January 21, 2022 2022 will be a pivotal year for shaping crypto regulation as the regulatory environment becomes clearer as regulatory hands will be forced. The Securities & Exchange Commission and other agencies will...
By: Cordell Eddings January 16, 2022 — If you were hoping for a quieter, less contentious, more predictable 2022, we think you'll be disappointed. You, and everybody else. Social scientists and cultural critics have noted the rise in nostalgia during the...